Esco Lifesciences Group is a world-leading life science company with a diversified portfolio and sales in over 100 countries. As a manufacturer of laboratory and biopharma equipment, and IVF medical devices, Esco offers tailored solutions that fit the needs of laboratories in various industries.
Esco contributes to meet the challenges of the 21st century with a diverse range of business units. The company continuously innovates its products to help the clinical and industrial laboratories achieve successful conclusions in research and development, quality control, and analysis. We continue to provide reliable world-class equipment to help pharmaceutical companies make their products safer and more cost-effective. And with the increasing demand of the IVF industry, we have developed efficient ART equipment to enable equitable access to infertility care.
Esco contributes to meet the challenges of the 21st century with a diverse range of business units. The company continuously innovates its products to help the clinical and industrial laboratories achieve successful conclusions in research and development, quality control, and analysis. We continue to provide reliable world-class equipment to help pharmaceutical companies make their products safer and more cost-effective. And with the increasing demand of the IVF industry, we have developed efficient ART equipment to enable equitable access to infertility care.
Location: United States, Pennsylvania, Horsham Township
Employees: 1001-5000
Phone: +65 6542 0833
Total raised: $200M
Founded date: 1978
Investors 1
| Date | Name | Website |
| - | Vivo Capit... | vivocapita... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 27.05.2021 | Series A | $200M | Novo Holdi... |
Mentions in press and media 9
| Date | Title | Description |
| 25.02.2025 | Esco Lifesciences Group and Allwin Medical Devices Announce Strategic Partnership | SINGAPORE and ANAHEIM, USA – Media Outreach Newswire – 25 February 2025 – Allwin Medical Devices Inc. (“Allwin”), a leading manufacturer of a wide range of medical devices addressing women’s health (IVF), urology, gastroenterology and inter... |
| 16.11.2021 | BREAKING: Chinese VC Bits x Bites hits $100m final close with capital from Syngenta, Wilbur-Ellis | Chinese agrifoodtech VC firm Bits x Bites has closed its latest fund on $100 million with a string of food and ag corporates as well as investment players signing up as LPs. Among those participating in the fund’s final close were Syngenta ... |
| 16.11.2021 | Chinese VC Bits x Bites hits $100m final close with capital from Syngenta, Wilbur-Ellis | Chinese agrifoodtech VC firm Bits x Bites has closed its latest fund on $100 million with a string of food and ag corporates as well as investment players signing up as LPs. Among those participating in the fund’s final close were Syngenta ... |
| 27.05.2021 | Esco raises $200M to set up Boston cell and gene therapy hub | Esco Lifesciences has raised $200 million in a series A and crossover round co-led by Novo Holdings and Vivo Capital. The Singapore-based company will use the cash to establish a hub for cell and gene therapy tools and technologies in Bosto... |
| 27.05.2021 | Esco Lifesciences Closes a Record-Setting US$200M Series A Round Led by Vivo Capital and Novo Holdings | SINGAPORE, May 26, 2021 /PRNewswire/ -- Esco Lifesciences ("Esco", the "Company") announced today the close of an over-subscribed US$200 million Series A and Crossover round. The financing was led by Vivo Capital and Nov... |
| 27.05.2021 | Esco Lifesciences Closes a Record-Setting US$200M Series A Round Led by Vivo Capital and Novo Holdings | SINGAPORE, May 27, 2021 /PRNewswire/ -- Esco Lifesciences ("Esco", the "Company") announced today the close of an over-subscribed US$200 million Series A and Crossover round. The financing was led by Vivo Capital and Nov... |
| 27.05.2021 | Esco Lifesciences Closes US$200M Series A Funding | Esco Lifesciences Group Logo Esco Lifesciences, a Singapore-based provider of life sciences tools and services, closed a US$200m Series A and Crossover round. The round was led by Vivo Capital and Novo Holdings A/S, with participation from ... |
| 26.05.2021 | Esco Lifesciences Closes a Record-Setting $200M Series A Round Led by Vivo Capital | - |
| 26.05.2021 | Esco Lifesciences Closes a Record-Setting US$200M Series A Round Led by Vivo Capital and Novo Holdings |